40 related articles for article (PubMed ID: 38476337)
1. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
Wu Y; Zhao L; Chai Y
Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.
Abbas H; Niazi M; Makker J
Am J Case Rep; 2017 May; 18():491-497. PubMed ID: 28469125
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of lung cancer coexisting with B‑cell lymphoma with pembrolizumab following rituximab‑included chemotherapy: A case report.
Natori D; Ozasa H; Shima Y; Mizumoto C; Suminaga K; Nomizo T; Ajimizu H; Yoshida H; Hirai T
Mol Clin Oncol; 2024 Apr; 20(4):33. PubMed ID: 38476337
[TBL] [Abstract][Full Text] [Related]
4. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
5. Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease.
Raderer M; Püspök A; Stummvoll G; Längle F; Chott A
Scand J Gastroenterol; 2003 Mar; 38(3):294-7. PubMed ID: 12737445
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary metastasis with coexisting pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma 20 years after endometrioid adenocarcinoma surgery: A case report.
Nakamura D; Kobayashi N; Miyazawa M; Miura K; Satomi H
Thorac Cancer; 2021 Feb; 12(3):402-406. PubMed ID: 33300291
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic Lymphoma Kinase (ALK) Mutation-Targeting Treatment With Alectinib in Lung Adenocarcinoma and Primary Cutaneous Marginal Zone B-Cell Lymphoma.
Ashish S; Rodriguez RR; Sethi P; Yu F; Raj M
Cureus; 2022 Oct; 14(10):e29922. PubMed ID: 36348885
[TBL] [Abstract][Full Text] [Related]
10. Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Nastoupil LJ; Chin CK; Westin JR; Fowler NH; Samaniego F; Cheng X; Ma MCJ; Wang Z; Chu F; Dsouza L; Obi C; Mims J; Feng L; Zhou S; Green M; Davis RE; Neelapu SS
Blood Adv; 2022 Feb; 6(4):1143-1151. PubMed ID: 35015819
[TBL] [Abstract][Full Text] [Related]
11. Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.
Osumo B; Radzevich J; Nashed N; Ustwani O; Slotman G
Am Surg; 2022 Apr; 88(4):799-801. PubMed ID: 34747234
[TBL] [Abstract][Full Text] [Related]
12. Marginal Zone Lymphoma and Lung Adenocarcinoma with an EGFR Exon 19 E746-S752del Mutation in a Patient with IgG4-related Disease.
Okawa S; Rai K; Fujii N; Gion Y; Ninomiya K; Kato Y; Taniguchi A; Kubo T; Ichihara E; Ohashi K; Miyahara N; Hotta K; Tabata M; Maeda Y; Kiura K
Intern Med; 2021 Sep; 60(17):2831-2837. PubMed ID: 33775999
[TBL] [Abstract][Full Text] [Related]
13. Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer.
Marumo Y; Kusumoto S; Masaki A; Nakashima T; Kikuchi T; Mori F; Komatsu H; Inagaki H; Iida S; Inagaki A
Int J Hematol; 2021 Aug; 114(2):280-285. PubMed ID: 33772730
[TBL] [Abstract][Full Text] [Related]
14. Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency.
Yuan S; Hu X; Zhao Y; Wang Z
Front Immunol; 2020; 11():563622. PubMed ID: 33240259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.
Armand P; Janssens A; Gritti G; Radford J; Timmerman J; Pinto A; Mercadal Vilchez S; Johnson P; Cunningham D; Leonard JP; Rodig SJ; Martín-Regueira P; Sumbul A; Samakoglu S; Tang H; Ansell SM
Blood; 2021 Feb; 137(5):637-645. PubMed ID: 32870269
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
